1-[3-Aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-[2′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa

This publication has 26 references indexed in Scilit:

• Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa
  Bioorganic & Medicinal Chemistry Letters, 2006
• Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2006
• Exosite-driven substrate specificity and function in coagulation
  Journal of Thrombosis and Haemostasis, 2005
• Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor
  Journal of Medicinal Chemistry, 2004
• Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor
  Journal of Medicinal Chemistry, 2003
• Visions & Reflections Factor Xa - a promising target for drug development
  Cellular and Molecular Life Sciences, 2002
• Nonpeptide Factor Xa Inhibitors III: Effects of DPC423, an Orally-Active Pyrazole Antithrombotic Agent, on Arterial Thrombosis in Rabbits
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Low-Molecular-Weight Heparins
  New England Journal of Medicine, 1997
• The international normalized ratio. A guide to understanding and correcting its problems
  Archives of internal medicine (1960), 1994
• Methods of Determining Plasma and Tissue Binding of Drugs
  Clinical Pharmacokinetics, 1992